Ultiva and Skin blushing/flushing - a phase IV clinical study of FDA data

Summary:

Skin blushing/flushing is reported as a side effect among people who take Ultiva (remifentanil hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Propofol, and have General anaesthesia.

The phase IV clinical study analyzes which people have Skin blushing/flushing when taking Ultiva. It is created by eHealthMe based on reports of 1,668 people who have side effects when taking Ultiva from the FDA, and is updated regularly.

What is Ultiva?

Ultiva has active ingredients of remifentanil hydrochloride. eHealthMe is studying from 1,671 Ultiva users. Check the latest studies of Ultiva.

What is Skin blushing/flushing?

Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 2,019 drugs and 2,930 conditions by eHealthMe. Check the latest studies of Skin blushing/flushing.

On Jul, 15, 2026

1,668 people reported to have side effects when taking Ultiva.
Among them, 16 people (0.96%) have Skin blushing/flushing.

Could Ultiva cause Skin blushing/flushing?

Among these 16 people:

How long have people been on Ultiva when they have Skin blushing/flushing? *

What is the gender of people who have Skin blushing/flushing when taking Ultiva? *

female: 50 %
male: 50 %

What is the age of people who have Skin blushing/flushing when taking Ultiva? *

What are other drugs people take besides Ultiva? *

What are other side effects people have besides Skin blushing/flushing? *

Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 8 people, 50.00%
Hypotension (abnormally low blood pressure): 7 people, 43.75%
Itching: 6 people, 37.50%
Swelling Face: 3 people, 18.75%
Hypersensitivity: 3 people, 18.75%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 3 people, 18.75%
Airway Peak Pressure Increased: 2 people, 12.50%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 12.50%
Rashes (redness): 2 people, 12.50%
Oxygen Saturation Decreased: 2 people, 12.50%

What are the existing conditions these people have? *

Volume Blood Decreased: 3 people, 18.75%
Hypotension (abnormally low blood pressure): 3 people, 18.75%
General Anaesthesia: 3 people, 18.75%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 12.50%
Epidural Anaesthesia: 2 people, 12.50%
Pulmonary Vascular Disorder: 1 person, 6.25%
Neuromuscular Blockade Reversal: 1 person, 6.25%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.25%
Haemorrhage (bleeding): 1 person, 6.25%
Cardiac Disorder: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ultiva and have Skin blushing/flushing?

- Check whether Skin blushing/flushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultiva:

Ultiva (1,671 reports)

Browse all side effects of Ultiva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,019 drugs)

Browse all the conditions that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,930 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on remifentanil hydrochloride (the active ingredients of Ultiva) and Ultiva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.